Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
Laure Farnault(Aix-Marseille Université), Régis Costello(Inserm), Robin Arcani(Inserm), Geoffroy Venton(Inserm), Bertrand Pourroy(Assistance Publique Hôpitaux de Marseille), Julien Colle(Inserm), Ivanov Vv(Hôpital de la Conception), Cédric Mercier(Inserm), Noémie Jourde‐Chiche(Aix-Marseille Université), R. Fanciullino(Hôpital de la Conception), Patricia Roche(St. Boniface Hospital)
Cited by 2
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
Acute Renal Infarction
|Clinical Journal of the American Society of Nephrology|2012|176
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
Clinical and Genetic Spectrum of Bartter Syndrome Type 3
|Journal of the American Society of Nephrology|2017|120
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
|Kidney International|2019|119